True, Investor2014. When you witness the comprehensive approach AVXL has undertaken in addressing this complex disease, NTRP's singular, narrow approach is clear to see. AVXL has had to sink in 2 extra years for this and IMO Missling's budget management to date has been exceptional. Bio-land is replete with examples of leadership looting investors.